Sundhedsvidenskabelig Forskning ved Aarhus - Institutleder til ...

INFEKTIONSMEDICINSK AFDELING, AALBORG SYGEHUS, ÅRHUS
UNIVERSITETSHOSPITAL
W, Tracy, R, Kuller, L, Shlipak, M, Angus, B, Klinker,
H, Ross, M, INSIGHT SMART Study Group,
Østergaard, LJ & Nielsen, HI 2009, ‘Interruption of
antiretroviral therapy is associated with increased
plasma cystatin C’, AIDS, vol. 23, nr. 1, s. 71-82.
Omland, LH, Jepsen, P, Skinhøj, P, Jørgensen, HL, Münster,
AB, Bangsborg, J, Fenger, M, Sørensen, HT &
Obel, N 2009, ‘The impact of HIV-1 co-infection on
long-term mortality in patients with hepatitis C: a
population-based cohort study’, HIV Medicine, vol.
10, nr. 2, s. 65-71.
Podlekareva, DN, Mocroft, A, Post, FA, Riekstina, V,
Miro, JM, Furrer, H, Bruyand, M, Panteleev, AM,
Rakhmanova, AG, Girardi, E, Losso, MH, Toibaro,
JJ, Caylá, J, Miller, RF, Obel, N, Skrahina,
A, Chentsova, N, Lundgren, JD, Kirk, O, [HIV/
TB Study Writing Group], Larsen [HIV/TB Study
Writing Group], CS & Pedersen [HIV/TB Study
Writing Group], G 2009, ‘Mortality from HIV and
TB coinfections is higher in Eastern Europe than
in Western Europe and Argentina’, AIDS, vol. 23,
nr. 18, s. 2485-95.
Rodger, AJ, Fox, Z, Lundgren, JD, Kuller, LH, Boesecke,
C, Gey, D, Skoutelis, A, Goetz, MB, Phillips, AN,
[INSIGHT Strategies for Management of Antiretroviral
Therapy (SMART) Study Group] & Nielsen
[INSIGHT (SMART) Study Group], HI 2009, ‘Activation
and coagulation biomarkers are independent
predictors of the development of opportunistic
disease in patients with HIV infection’, Journal of
Infectious Diseases, vol. 200, nr. 6, s. 973-83.
Santos, JR, Llibre, JM, Ferrer, E, Domingo, P, Imaz, A,
Moltó, J, Martin-Iguacel, R, Caum, C, Podzamczer,
D & Clotet, B 2009, ‘Efficacy and safety of switching
from enfuvirtide to raltegravir in patients with
virological suppression’, HIV Clinical Trials, vol. 10,
nr. 6, s. 432-8.
Søgaard, OS, Lohse, N, Gerstoft, J, Kronborg, G, Østergaard,
L, Pedersen, C, Pedersen, G, Sørensen, HT
& Obel, N 2009, ‘Mortality after hospitalization for
pneumonia among individuals with HIV, 1995-
2008: a Danish cohort study’, PLoS ONE, vol. 4, nr.
9, s. e7022.
Thusgaard, M, Christensen, JH, Mørn, B, Andersen,
T, Vige, R, Arildsen, H, Schmidt, EB & Nielsen,
H 2009, ‘Effect of fish oil (n-3 polyunsaturated
fatty acids) on plasma lipids, lipoproteins and
inflammatory markers in HIV-infected patients
treated with antiretroviral therapy: A randomized,
double-blind, placebo-controlled study’, Scandinavian
Journal of Infectious Diseases, vol. 41, nr. 10, s.
760-6.
Vinter, H & Nielsen, HI 2009, ‘Legionella pneumoni
hos patienter, der er i behandling med infliximab’,
Ugeskrift for læger, vol. 171, nr. 4, s. 247.
INSIGHT-ESPRIT Study Group, SILCAAT Scientific Committee,
Abrams, D, Lévy, Y, Losso, MH, Babiker,
A, Collins, G, Cooper, DA, Darbyshire, J, Emery, S,
Fox, L, Gordin, F, Lane, HC, Lundgren, JD, Mitsuyasu,
R, Neaton, JD, Phillips, A, Routy, JP, Tambussi,
G, Wentworth, D & Nielsen [ESPRIT / SILCAAT
Group], HI 2009, ‘Interleukin-2 therapy in patients
with HIV infection’, New England Journal of Medicine,
vol. 361, nr. 16, s. 1548-59.
Artikel
Sørensen, LØ 2009, ‘Gonoré 2008’, E P I - Nyt, vol. 22, s.
1-2.
Sundhedsvidenskabelig Forskning ved Aarhus Universitet og Århus Universitetshospital 2009 293